Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Invest New Drugs
2021 Apr 01;392:377-385. doi: 10.1007/s10637-020-01008-y.
Show Gene links
Show Anatomy links
rAj-Tspin, a novel recombinant peptide from Apostichopus japonicus, suppresses the proliferation, migration, and invasion of BEL-7402 cells via a mechanism associated with the ITGB1-FAK-AKT pathway.
Yu P
,
Wu R
,
Zhou Z
,
Zhang X
,
Wang R
,
Wang X
,
Lin S
,
Wang J
,
Lv L
.
???displayArticle.abstract???
Purpose Our study aimed to investigate the antitumor effects of rAj-Tspin on BEL-7402 hepatocellular carcinoma cells and to explore the underlying mechanism. Method For the in vivo experiment, BEL-7402 cells were inoculated subcutaneously into the axilla of nude mice to generate a BEL-7402 cell-bearing model, and model mice were then treated with different doses of rAj-Tspin. A CCK-8 assay was used to evaluate the in vitro viability of BEL-7402 and LO2 cells after treatment with different concentrations of rAj-Tspin. The effects of rAj-Tspin on BEL-7402 cell apoptosis, migration and invasion were evaluated by AO/EB and Hoechst fluorescent staining and by scratch and Transwell assays, and the tumor-suppressive mechanism of rAj-Tspin was explored by Western blotting. Results rAj-Tspin suppressed the proliferation of BEL-7402 cells with an IC50 of 0.89 μM. The results of both microscopic analysis and Western blotting suggested that rAj-Tspin induced the apoptosis of BEL-7402 cells through a mitochondria-dependent pathway. Furthermore, rAj-Tspin disrupted EMT; this disruption ultimately caused BEL-7402 cells to lose their shape and decreased their migration and invasion. Moreover, rAj-Tspin might inhibit the proliferation and metastasis of BEL-7402 cells through the ITGB1-FAK-AKT pathway. Conclusion rAj-Tspin exerts an antitumor effect through the ITGB1-FAK-Akt signaling pathway and exhibits low toxicity at an effective dose.
Abou-Alfa,
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.
2018, Pubmed
Abou-Alfa,
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.
2018,
Pubmed
Brabletz,
EMT in cancer.
2018,
Pubmed
Chavez-Tapia,
Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease.
2012,
Pubmed
Correia-da-Silva,
Anticancer and cancer preventive compounds from edible marine organisms.
2017,
Pubmed
,
Echinobase
Daubon,
Deciphering the complex role of thrombospondin-1 in glioblastoma development.
2019,
Pubmed
Duan,
Exogenous Let-7a-5p Induces A549 Lung Cancer Cell Death Through BCL2L1-Mediated PI3Kγ Signaling Pathway.
2019,
Pubmed
Ferlay,
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.
2019,
Pubmed
Huang,
ITGBL1 promotes cell migration and invasion through stimulating the TGF-β signalling pathway in hepatocellular carcinoma.
2020,
Pubmed
Jin,
Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery.
2019,
Pubmed
Kim,
Skin whitening and anti-corrugation activities of glycoprotein fractions from liquid extracts of boiled sea cucumber.
2016,
Pubmed
,
Echinobase
Lagente,
Modulation of cytokine-induced eosinophil infiltration by phosphodiesterase inhibitors.
1995,
Pubmed
Li,
A novel structural fucosylated chondroitin sulfate from Holothuria Mexicana and its effects on growth factors binding and anticoagulation.
2018,
Pubmed
,
Echinobase
Li,
Role of thrombospondin 1 in liver diseases.
2017,
Pubmed
Li,
lncRNA H19 Alleviated Myocardial I/RI via Suppressing miR-877-3p/Bcl-2-Mediated Mitochondrial Apoptosis.
2019,
Pubmed
Lopez-Ramirez,
Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations.
2017,
Pubmed
Lorenz,
Mechanosensing by β1 integrin induces angiocrine signals for liver growth and survival.
2018,
Pubmed
Morley,
The senescence accelerated mouse (SAMP8) as a model for oxidative stress and Alzheimer's disease.
2012,
Pubmed
Poon,
Clinical significance of thrombospondin 1 expression in hepatocellular carcinoma.
2004,
Pubmed
Shao,
The anti-tumour activity of rLj-RGD4, an RGD toxin protein from Lampetra japonica, on human laryngeal squamous carcinoma Hep-2 cells in nude mice.
2015,
Pubmed
Shen,
Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer.
2018,
Pubmed
Venkatraman,
The CD47-binding peptide of thrombospondin-1 induces defenestration of liver sinusoidal endothelial cells.
2013,
Pubmed
Wang,
The anti-tumor effects of the recombinant toxin protein rLj-RGD3 from Lampetra japonica on pancreatic carcinoma Panc-1 cells in nude mice.
2017,
Pubmed
Xie,
MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
2019,
Pubmed
Yamashiro,
Matrix mechanotransduction mediated by thrombospondin-1/integrin/YAP in the vascular remodeling.
2020,
Pubmed
Yang,
Augmenting the therapeutic efficacy of adenosine against pancreatic cancer by switching the Akt/p21-dependent senescence to apoptosis.
2019,
Pubmed
Yang,
HDAC6 Suppresses Let-7i-5p to Elicit TSP1/CD47-Mediated Anti-Tumorigenesis and Phagocytosis of Hepatocellular Carcinoma.
2019,
Pubmed
Zhang,
Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling.
2016,
Pubmed
Zhang,
Cyclovirobuxine D Exerts Anticancer Effects by Suppressing the EGFR-FAK-AKT/ERK1/2-Slug Signaling Pathway in Human Hepatocellular Carcinoma.
2020,
Pubmed
